Leading Pharma Competitors and Similar CompaniesClear all

Leading Pharma's competitors and similar companies include Aoxing Pharmaceutical, Grupo Menarini, Interbat and Yuyu Pharma.

	Leading Pharma Leading Pharma is a generic pharmaceutical company that purchases, licenses, develops, manufactures and distributes products to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S.	Aoxing Pharmaceutical Aoxing Pharmaceutical is a specialty pharmaceutical company.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	Interbat Interbat is a pharmaceutical company.	Yuyu Pharma Yuyu Pharma (유유제약, formerly known as YuYu) is a company that manufactures, distributes, and develops medicines.
Founding Date	Founding Date 2014	Founding Date 2002	Founding Date 1961	Founding Date 1948	Founding Date 1941
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Fairfield, US HQ	Locations Shijiazhuang Shi, CN HQ Shijiazhuang Shi, CN Foster City, US	Locations Badalona, ES HQ	Locations ID HQ	Locations Seoul, KR HQ Anyang, KR Bucheon, KR Busan, KR Changwon Si, KR Daegu, KR Daejeon, KR see more
Employees	Employees 1031% increase	Employees 346	Employees 5541% increase	Employees 9272% increase	Employees 253
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $32.3m (FY, 2016)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩137.2b (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods $7.8m (FY, 2016)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩85.1b (FY, 2023)
Gross profit	Gross profit N/A	Gross profit $24.6m (FY, 2016)	Gross profit N/A	Gross profit N/A	Gross profit ₩53.4b (FY, 2023)
Net income	Net income N/A	Net income $2.1m (FY, 2016)	Net income N/A	Net income N/A	Net income (₩5.5b) (FY, 2023)